Selective elimination of erosive cells
The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
12.03.2014
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
|---|---|
| AbstractList | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention relates to the treatment of osteoarthritis, osteoporosis, psoriatic arthritis or rheumatic arthritis with an anti-NKG2A antibody. |
| Author | GALSGAARD ELISABETH DOUGLAS SOEDERSTROEM KALLE |
| Author_xml | – fullname: SOEDERSTROEM KALLE – fullname: GALSGAARD ELISABETH DOUGLAS |
| BookMark | eNrjYmDJy89L5WRQC07NSU0uySxLVUjNyczNzEssyczPU8hPU0gtyi8GCSen5uQU8zCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_QwNjM2NTEwtzR2Ni1AAAZwwpdw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | CN103635487A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CN103635487A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:20:48 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Chinese English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CN103635487A3 |
| Notes | Application Number: CN201280029746 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140312&DB=EPODOC&CC=CN&NR=103635487A |
| ParticipantIDs | epo_espacenet_CN103635487A |
| PublicationCentury | 2000 |
| PublicationDate | 20140312 |
| PublicationDateYYYYMMDD | 2014-03-12 |
| PublicationDate_xml | – month: 03 year: 2014 text: 20140312 day: 12 |
| PublicationDecade | 2010 |
| PublicationYear | 2014 |
| RelatedCompanies | NOVO NORDISK AS |
| RelatedCompanies_xml | – name: NOVO NORDISK AS |
| Score | 3.039041 |
| Snippet | The current invention relates to the treatment of diseases characterized by cartilage destruction and/or bone erosion. In particular the present invention... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Selective elimination of erosive cells |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140312&DB=EPODOC&locale=&CC=CN&NR=103635487A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FTc_qCB9K67fy0MRl7YMYd3QKXsbSU1RETdsRfDXexc654u-hQtckoP7zH0AXPTUo_AFlSgzIS1P9CjQFEgrZI4SzJPKZVScPMqC4b13M_NnDXhZ1cLoPqGfujkiclSO_F5peb1cB7FinVtZXspnBC2u0mkUm7V3TM3nbMeMB1EyGcdjbnIe8czMbtHWdVG1onV-vQGbaEaHxA3Jw4CqUpa_VUq6C1sTxPZW7UHj66kNLb6avNaG7VH94Y3LmvfKfTDv9MgalE6GetWzuOiaxqIwFGo6AlMQvjyA8zSZ8qGFB85_Xjfn2fpu7iE00etXR2D0-3luS98J0YXxhAxELgrGCiSgm7tM-B3o_o2n-9_mMewQpSiRynZOoFm9f6hT1KyVPNMk-QZ6i30l |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FZ1fFaRvxa2fy0MRl65UXbuhVfZWkpqiIm7YiuCv9xI654u-hQtckoP7zH0AnHXFI3OYLFEmjBs268pAk8sNj5iCEZsLi8ji5Dhxo3v7eupMG_CyqIVRfUI_VXNE5Kgc-b1S8nq-DGIFKreyPOfPCJpdhKkf6LV3LJvP9Uw9GPjDyTgYU51SnyZ6cou2roWqFa3zyxVYRRPbk9wwfBjIqpT5b5USbsLaBLG9VVvQ-HpqQ4suJq-1YT2uP7xxWfNeuQ36nRpZg9JJE69qFpe8pjYrNIGaToJlEL7cgdNwmNLIwAOzn9dlNFnezdqFJnr9Yg-0fj_Pe9wxPXRhbMZdlrOCkAIJaOUWYc4-dP7G0_lv8wRaURqPstFVcnMAG5JqMqmqZx5Cs3r_EEeoZSt-rMjzDYP-gBg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Selective+elimination+of+erosive+cells&rft.inventor=SOEDERSTROEM+KALLE&rft.inventor=GALSGAARD+ELISABETH+DOUGLAS&rft.date=2014-03-12&rft.externalDBID=A&rft.externalDocID=CN103635487A |